Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16107083 | 0.98 | CES2 (0.63) | CES2HTTMEN1THRBKMT2A | |
| SCHEMBL1633949 | 0.98 | CES2 (0.63) | CES2HTTMEN1THRBKMT2A | |
| SCHEMBL1635179 | 0.98 | CES2 (0.63) | CES2HTTMEN1THRBKMT2A | |
| SCHEMBL1636629 | 0.98 | CES2 (0.63) | CES2HTTMEN1THRBKMT2A | |
| SCHEMBL14939700 | 0.98 | CES2 (0.63) | CES2HTTMEN1THRBKMT2A | |
| SCHEMBL25424773 | 0.98 | CES2 (0.63) | CES2HTTMEN1THRBKMT2A | |
| SCHEMBL28736760 | 0.96 | CES2 (0.61) | CES2HTTMEN1THRBKMT2A | |
| SCHEMBL6408574 | 0.93 | — | — | |
| SCHEMBL871697 | 0.90 | CES2 (0.44) | CES2HTTMEN1THRBKMT2A | |
| SCHEMBL5989968 | 0.88 | TSHR (0.50) | CES2HTTMEN1THRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932293-B2 | Aldehyde compositions and methods for providing fragrance containing the same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2011-04-26 | — | — | US | disclosed |
| US-7932293-B2 | Aldehyde compositions and methods for providing fragrance containing the same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2011-04-26 | — | — | US | disclosed |
| US-7932293-B2 | Aldehyde compositions and methods for providing fragrance containing the same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2011-04-26 | — | — | US | disclosed |
| US-20080319088-A1 | Aldehyde Compositions and Methods for Providing Fragrance Containing the Same | SMITH CATHERINE MARIE | 2008-12-25 | — | — | US | disclosed |
| US-20080319088-A1 | Aldehyde Compositions and Methods for Providing Fragrance Containing the Same | SMITH CATHERINE MARIE | 2008-12-25 | — | — | US | disclosed |
| US-20080319088-A1 | Aldehyde Compositions and Methods for Providing Fragrance Containing the Same | SMITH CATHERINE MARIE | 2008-12-25 | — | — | US | disclosed |
| EP-1080084-B1 | PROCESS FOR EPOXIDATION OF ARYL ALLYL ETHERS | DOW GLOBAL TECHNOLOGIES INC (US) | 2004-05-06 | — | — | EP | disclosed |
| CN-1303382-A | Epoxidation process for aryl allyl ethers | DOW CHEMICAL CO (US) | 2001-07-11 | — | — | CN | disclosed |
| EP-1080084-A2 | PROCESS FOR EPOXIDATION OF ARYL ALLYL ETHERS | THE DOW CHEMICAL COMPANY (US) | 2001-03-07 | — | — | EP | disclosed |
| US-6087513-A | REACTION OF ALLYL ARYL ETHER WITH HYDROGEN PEROXIDE IN THE PRESENCE OF TRANSITION METALS FOR OXIDATION | THE DOW CHEMICAL COMPANY (US) | 2000-07-11 | — | — | US | disclosed |
| WO-1999062894-A2 | PROCESS FOR EPOXIDATION OF ARYL ALLYL ETHERS | THE DOW CHEMICAL COMPANY (US) | 1999-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319088-A1 | Aldehyde Compositions and Methods for Providing Fragrance Containing the Same | ALDH1A1, ALDH5A1, ALDH3A1 | CES2 367/4885HTT 4331/4885MEN1 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.